Literature DB >> 18835014

Matrix metalloproteinase-9 (MMP-9) in allergic nasal polyps.

Guler Bugdayci1, Mustafa Kaymakci, Neslihan Bukan.   

Abstract

Matrix metalloproteinases (MMPs) are known to play important roles in the invasion of nasal mucosa by inflammatory cells through degradation of extracellular matrix. Matrix metalloproteinase-9 (MMP-9) is considered to play a role in the pathogenesis of nasal polyp. The aim of the present study was to compare plasma MMP-9 levels of patients with nasal polyp of different etiologic origins, those with allergic nasal polyp (ANP) and non-allergic nasal polyp (NANP). In all, 29 patients (20 NANP and 9 ANP) and 20 healthy subjects were included in this study. Plasma MMP-9 levels were measured using ELISA. Plasma MMP-9 levels were higher (p<0.05) in ANP patients than in NANP patients and controls. In the group with ANP, plasma MMP-9 levels showed a positive correlation (p<0.05) with eosinophil counts. Plasma MMP-9 levels of NANP patients and control groups were similar (p>0.05). Moreover, that the highest levels of MMP-9 were in ANP patients may indicate the usefulness of this parameter in differentiating between the different etiologic origins of nasal polyp. Further studies are required to elaborate on the relationship between MMP-9 levels and allergic reactions. 2008 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18835014     DOI: 10.1016/j.acthis.2008.07.002

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  2 in total

1.  Matrix metalloproteinase-9 gene polymorphisms in nasal polyposis.

Authors:  Ling-Feng Wang; Chen-Yu Chien; Chih-Feng Tai; Wen-Rei Kuo; Edward Hsi; Suh-Hang Hank Juo
Journal:  BMC Med Genet       Date:  2010-06-09       Impact factor: 2.103

2.  IL-25-induced activation of nasal fibroblast and its association with the remodeling of chronic rhinosinusitis with nasal polyposis.

Authors:  Soo-Kyoung Park; Yong-De Jin; Yeong-Kyu Park; Sun-Hee Yeon; Jun Xu; Rui-Ning Han; Ki-Sang Rha; Yong-Min Kim
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.